- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04266041
High-density EEG in Neurological Disorders
July 31, 2023 updated by: Yinchen Song, Dartmouth-Hitchcock Medical Center
The purpose of the study is to use a new method of high-density electroencephalogram (HD-EEG) recording to map brain areas important for movement, sensation, language, emotion, and cognition.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Detailed Description
This study will measure brain waves using high-density EEG.
Participants will be asked wear a cap with electrodes attached to it.
During the recording, participants may be asked to rest, sleep, or complete a task.
The tasks involve viewing pictures, answering questions, speaking, or moving an arm or leg.
Recordings generally last between 60-120 minutes.*
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Able to perform the tasks
- Able to give own consent
Exclusion Criteria:
- Any neurologic or psychiatric diagnosis such as stroke, tumor, or psychosis judged to interfere with high-density EEG.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-density EEG localization in epilepsy
High-density EEG will be used for brain localization in epilepsy patients
|
This study will focus on obtaining a special type of high-density scalp electroencephalography (HD-EEG) recordings in patients with neurological disorders (i.e., epilepsy, brain tumor, stroke, etc.) and appropriately matched controls.
HD-EEG is a scalp EEG which uses up to 256 channels compared to the standard 21 channels used for routine clinical applications.
The reason for using more channels to record is for more precise localization of epileptogenic foci and/or more precise mapping of brain functions.
This type of EEG requires the use of patient's own MRI scan to precisely localize activity.
Therefore, all patients and controls getting an HD-EEG will require a structural MRI scan.
|
Active Comparator: High-density EEG localization in healthy controls
High-density EEG will be used for brain localization in healthy controls
|
This study will focus on obtaining a special type of high-density scalp electroencephalography (HD-EEG) recordings in patients with neurological disorders (i.e., epilepsy, brain tumor, stroke, etc.) and appropriately matched controls.
HD-EEG is a scalp EEG which uses up to 256 channels compared to the standard 21 channels used for routine clinical applications.
The reason for using more channels to record is for more precise localization of epileptogenic foci and/or more precise mapping of brain functions.
This type of EEG requires the use of patient's own MRI scan to precisely localize activity.
Therefore, all patients and controls getting an HD-EEG will require a structural MRI scan.
|
Experimental: High-density EEG localization in tumor patients
High-density EEG will be used for brain localization in tumor patients
|
This study will focus on obtaining a special type of high-density scalp electroencephalography (HD-EEG) recordings in patients with neurological disorders (i.e., epilepsy, brain tumor, stroke, etc.) and appropriately matched controls.
HD-EEG is a scalp EEG which uses up to 256 channels compared to the standard 21 channels used for routine clinical applications.
The reason for using more channels to record is for more precise localization of epileptogenic foci and/or more precise mapping of brain functions.
This type of EEG requires the use of patient's own MRI scan to precisely localize activity.
Therefore, all patients and controls getting an HD-EEG will require a structural MRI scan.
|
Experimental: High-density EEG localization in peripheral nerve patients
High-density EEG will be used for brain localization in patients with peripheral nerve dysfunction
|
This study will focus on obtaining a special type of high-density scalp electroencephalography (HD-EEG) recordings in patients with neurological disorders (i.e., epilepsy, brain tumor, stroke, etc.) and appropriately matched controls.
HD-EEG is a scalp EEG which uses up to 256 channels compared to the standard 21 channels used for routine clinical applications.
The reason for using more channels to record is for more precise localization of epileptogenic foci and/or more precise mapping of brain functions.
This type of EEG requires the use of patient's own MRI scan to precisely localize activity.
Therefore, all patients and controls getting an HD-EEG will require a structural MRI scan.
|
Experimental: High-density EEG localization in stroke patients
High-density EEG will be used for brain localization in patients who have recently experienced a stroke
|
This study will focus on obtaining a special type of high-density scalp electroencephalography (HD-EEG) recordings in patients with neurological disorders (i.e., epilepsy, brain tumor, stroke, etc.) and appropriately matched controls.
HD-EEG is a scalp EEG which uses up to 256 channels compared to the standard 21 channels used for routine clinical applications.
The reason for using more channels to record is for more precise localization of epileptogenic foci and/or more precise mapping of brain functions.
This type of EEG requires the use of patient's own MRI scan to precisely localize activity.
Therefore, all patients and controls getting an HD-EEG will require a structural MRI scan.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Localize brain functions in patients and healthy controls
Time Frame: 60 - 90 minutes
|
Localize brain functions using high-density EEG recordings
|
60 - 90 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Localize brain areas involved in language
Time Frame: 60 - 90 minutes
|
Localize brain areas involved in language using high-density EEG recordings
|
60 - 90 minutes
|
Localize brain areas involved in movement
Time Frame: 60 - 90 minutes
|
Localize brain areas involved in movement using high-density EEG recordings
|
60 - 90 minutes
|
Localize brain areas involved in sensation
Time Frame: 60 - 90 minutes
|
Localize brain areas involved in sensation using high-density EEG recordings
|
60 - 90 minutes
|
Localize brain areas involved in emotion
Time Frame: 60 - 90 minutes
|
Localize brain areas involved in emotion using high-density EEG recordings
|
60 - 90 minutes
|
Localize brain areas involved in memory
Time Frame: 60 - 90 minutes
|
Localize brain areas involved in memory using high-density EEG recordings
|
60 - 90 minutes
|
Localize brain areas associated with lesions
Time Frame: 60 - 90 minutes
|
Localize brain areas associated with lesions using high-density EEG recordings
|
60 - 90 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2018
Primary Completion (Estimated)
February 9, 2028
Study Completion (Estimated)
March 9, 2028
Study Registration Dates
First Submitted
February 10, 2020
First Submitted That Met QC Criteria
February 10, 2020
First Posted (Actual)
February 12, 2020
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 31, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D18111 30813
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on High-density electroencephalogram (HD-EEG)
-
Centre Integre Universitaire de Sante et Services...Not yet recruiting
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Recruiting
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)CompletedSeizures | Heart ArrestUnited States
-
University of Dublin, Trinity CollegeMotor Neurone Disease Association, UK; Irish Research Council, IE; Research Motor... and other collaboratorsRecruitingALS (Amyotrophic Lateral Sclerosis) | Postpoliomyelitis Syndrome | Spinal Muscular AtrophyIreland
-
University Hospital, BordeauxRecruitingEpilepsy | Parkinson DiseaseFrance
-
University of Wisconsin, MadisonCompleted
-
Baptist Health South FloridaFlorida International UniversityWithdrawnMajor Depression | Repetitive Transcranial Magnetic StimulationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, China
-
Air Force Military Medical University, ChinaRecruitingPostoperative Cognitive Dysfunction | Aging | EEG With Periodic AbnormalitiesChina
-
Northern Arizona UniversityKidabilities Occupational Therapy ClinicUnknownPediatric ALL | Executive FunctioningUnited States